Use of sentinel lymph node biopsy for melanoma in children and adolescents

Journal of Surgical Oncology

Volumn 102, Issue 6, 2010, Pages 634-639

  Raval, Mehul V ^a,b,c   Bilimoria, Karl Y ^a,c   Bentrem, David J ^c,d   Stewart, Andrew K ^a   Ko, Clifford Y ^a,e   Reynolds, Marleta ^b   Wayne, Jeffrey D ^c  

^a AMERICAN COLLEGE OF SURGEONS   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

melanoma; National Cancer Data Base; pediatric oncology; pediatric surgery; sentinel lymph node biopsy

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; INFANT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTICENTER STUDY; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SENTINEL LYMPH NODE BIOPSY; SOCIOECONOMICS; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LYMPHATIC METASTASIS; MALE; MELANOMA; NEOPLASM STAGING; REGISTRIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 78349282979     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21683     Document Type: Article

References (44)

1. Downard CD, Rapkin LB, Gow KW,: Melanoma in children and adolescents. Surg Oncol 2007; 16: 215-220.
2. Desmond RA, Soong SJ,: Epidemiology of malignant melanoma. Surg Clin North Am 2003; 83: 1-29.
3. Strouse JJ, Fears TR, Tucker MA, et al.: Pediatric melanoma: Risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 2005; 23: 4735-4741.
4. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
5. Livestro DP, Kaine EM, Michaelson JS, et al.: Melanoma in the young: Differences and similarities with adult melanoma: A case-matched controlled analysis. Cancer 2007; 110: 614-624.
6. Howman-Giles R, Shaw HM, Scolyer RA, et al.: Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients. Ann Surg Oncol 2010; 17: 138-143.
7. Kayton ML, La Quaglia MP,: Sentinel node biopsy for melanocytic tumors in children. Semin Diagn Pathol 2008; 25: 95-99.
8. Mills O, Messina JL,: Pediatric melanoma: A review. Cancer Control 2009; 16: 225-233.
9. National Cancer Institute: Unusual Cancers of Childhood Treatment (PDQ®)-Skin Cancer (Melanoma, Basal Cell Carcinoma, and Squamous Cell Carcinoma). Available at:, 2009.
10. National Comprehensive Cancer Network: Available at:, 2009.
11. American Joint Committee on Cancer: AJCC Cancer Staging Manual, 6th edition. Chicago, IL: Springer; 2002.
12. Bilimoria KY, Balch CM, Wayne JD, et al.: Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States. J Clin Oncol 2009; 27: 1857-1863.
13. Cormier JN, Xing Y, Ding M, et al.: Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 2005; 23: 6054-6062.
14. Bilimoria KY, Balch CM, Bentrem DJ, et al.: Complete lymph node dissection for sentinel node-positive melanoma: Assessment of practice patterns in the United States. Ann Surg Oncol 2008; 15: 1566-1576.
15. Aldrink JH, Selim MA, Diesen DL, et al.: Pediatric melanoma: A single-institution experience of 150 patients. J Pediatr Surg 2009; 44: 1514-1521.
16. Butter A, Hui T, Chapdelaine J, et al.: Melanoma in children and the use of sentinel lymph node biopsy. J Pediatr Surg 2005; 40: 797-800.
17. Bilimoria KY, Stewart AK, Winchester DP, et al.: The National Cancer Data Base: A powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008; 15: 683-690.
18. Commission on Cancer: Approval Categories. Available at:, [Vol. revised August 30, 2005], 2008.
19. Childrens Oncology Group Cure Search: Available at:, Vol. January 19, 2009, 2009.
20. Grovas A, Fremgen A, Rauck A, et al.: The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer 1997; 80: 2321-2332.
21. Lange JR, Palis BE, Chang DC, et al.: Melanoma in children and teenagers: An analysis of patients from the National Cancer Data Base. J Clin Oncol 2007; 25: 1363-1368.
22. National Cancer Institute: SEER Surveillance Epidemiology and End Results. Available at:, 2008.
23. National Program of Cancer Registries (NPCR): Cancer Surveillance System Rationale and Approach. Available at:, 2008.
24. National Cancer Registrars Association: Certification. Available at:, 2008.
25. Standards for Cancer Registries: Data Standards adn Data Dictionary, Vol. II. Springfield, IL: North American Association of Central Cancer Registries; 2003.
26. Fritz A, Percy C, Jack A, et al.: International Classification of Diseases for Oncology, 3rd edition. Geneva: World Helath Organization; 2000.
27. FORDS: Facility Oncolgy Registry Data Standards-Revised for 2007. Chicago, IL: Commission on Cancer, American College of Surgeons; 2007.
28. Panageas KS, Schrag D, Riedel E, et al.: The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med 2003; 139: 658-665.
29. Hosmer DW, Hosmer T, Le Cessie S, et al.: A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997; 16: 965-980.
30. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
31. Gow KW, Rapkin LB, Olson TA, et al.: Sentinel lymph node biopsy in the pediatric population. J Pediatr Surg 2008; 43: 2193-2198.
32. Roaten JB, Partrick DA, Bensard D, et al.: Survival in sentinel lymph node-positive pediatric melanoma. J Pediatr Surg 2005; 40: 988-992, discussion 992.
33. Roaten JB, Partrick DA, Pearlman N, et al.: Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents. J Pediatr Surg 2005; 40: 232-235. (Pubitemid 40143564)
34. Gamblin TC, Edington H, Kirkwood JM, et al.: Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features. Ann Surg Oncol 2006; 13: 1664-1670.
35. Su LD, Fullen DR, Sondak VK, et al.: Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: A report on 18 patients. Cancer 2003; 97: 499-507.
36. Ludgate MW, Fullen DR, Lee J, et al.: The atypical Spitz tumor of uncertain biologic potential: A series of 67 patients from a single institution. Cancer 2009; 115: 631-641.
37. Shah NC, Gerstle JT, Stuart M, et al.: Use of sentinel lymph node biopsy and high-dose interferon in pediatric patients with high-risk melanoma: The Hospital for Sick Children experience. J Pediatr Hematol Oncol 2006; 28: 496-500.
38. Morton DL, Thompson JF, Cochran AJ, et al.: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307-1317.
39. Cockburn MG, Zadnick J, Deapen D,: Developing epidemic of melanoma in the Hispanic population of California. Cancer 2006; 106: 1162-1168.
40. Eide MJ, Weinstock MA, Clark MA,: Demographic and socioeconomic predictors of melanoma prognosis in the United States. J Health Care Poor Underserved 2009; 20: 227-245.
41. Pacella SJ, Lowe L, Bradford C, et al.: The utility of sentinel lymph node biopsy in head and neck melanoma in the pediatric population. Plast Reconstr Surg 2003; 112: 1257-1265. (Pubitemid 43933910)
42. Toro J, Ranieri JM, Havlik RJ, et al.: Sentinel lymph node biopsy in children and adolescents with malignant melanoma. J Pediatr Surg 2003; 38: 1063-1065.
43. Chao C, Martin RC II, Ross MI, et al.: Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol 2004; 11: 259-264.
44. Bilimoria KY, Bentrem DJ, Stewart AK, et al.: Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: Implications for studies that use the National Cancer Data Base. J Clin Oncol 2009; 27: 4177-4181.